Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119515823 | 11951582 | 3 | F | 20150201 | 20160706 | 20160126 | 20160719 | EXP | US-ACORDA-ACO_108874_2015 | ACORDA | 70.78 | YR | F | Y | 64.85000 | KG | 20160719 | OT | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119515823 | 11951582 | 1 | PS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | Y | 075088 | 22250 | 10 | MG | TABLET | BID | ||||
| 119515823 | 11951582 | 2 | SS | AMPYRA | DALFAMPRIDINE | 1 | Y | 22250 | TABLET | ||||||||||
| 119515823 | 11951582 | 3 | SS | TECFIDERA | DIMETHYL FUMARATE | 1 | Oral | 240 MG, UNK | Y | U | 0 | 240 | MG | BID | |||||
| 119515823 | 11951582 | 4 | C | DIGOXIN. | DIGOXIN | 1 | Unknown | UNK | U | 0 | |||||||||
| 119515823 | 11951582 | 5 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 119515823 | 11951582 | 6 | C | BACLOFEN. | BACLOFEN | 1 | Unknown | UNK | U | 0 | |||||||||
| 119515823 | 11951582 | 7 | C | Fish oil | FISH OIL | 1 | Unknown | UNK | U | 0 | |||||||||
| 119515823 | 11951582 | 8 | C | Calcium | CALCIUM | 1 | Unknown | UNK | U | 0 | |||||||||
| 119515823 | 11951582 | 9 | C | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 119515823 | 11951582 | 10 | C | WARFARIN SODIUM. | WARFARIN SODIUM | 1 | Unknown | UNK | U | 0 | |||||||||
| 119515823 | 11951582 | 11 | C | ^New antiarrhythmic medication^ | 2 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119515823 | 11951582 | 1 | Gait disturbance |
| 119515823 | 11951582 | 2 | Multiple sclerosis |
| 119515823 | 11951582 | 3 | Multiple sclerosis |
| 119515823 | 11951582 | 4 | Product used for unknown indication |
| 119515823 | 11951582 | 5 | Product used for unknown indication |
| 119515823 | 11951582 | 6 | Product used for unknown indication |
| 119515823 | 11951582 | 7 | Product used for unknown indication |
| 119515823 | 11951582 | 8 | Product used for unknown indication |
| 119515823 | 11951582 | 9 | Product used for unknown indication |
| 119515823 | 11951582 | 10 | Product used for unknown indication |
| 119515823 | 11951582 | 11 | Arrhythmia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119515823 | 11951582 | HO |
| 119515823 | 11951582 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119515823 | 11951582 | Arrhythmia | |
| 119515823 | 11951582 | Drug dose omission | |
| 119515823 | 11951582 | Drug effect decreased | |
| 119515823 | 11951582 | Drug interaction | |
| 119515823 | 11951582 | Dry mouth | |
| 119515823 | 11951582 | Eye irritation | |
| 119515823 | 11951582 | Fall | |
| 119515823 | 11951582 | Flushing | |
| 119515823 | 11951582 | Hyperhidrosis | |
| 119515823 | 11951582 | Ill-defined disorder | |
| 119515823 | 11951582 | Loss of consciousness | |
| 119515823 | 11951582 | Memory impairment | |
| 119515823 | 11951582 | Seizure | |
| 119515823 | 11951582 | Therapeutic response unexpected | |
| 119515823 | 11951582 | Vulvovaginal burning sensation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119515823 | 11951582 | 1 | 201307 | 201601 | 0 | |
| 119515823 | 11951582 | 3 | 201501 | 20150130 | 0 |